Our finding that several diseases show lowered blood NAD + levels and overall imbalanced redox metabolites is intriguing, as it suggests that a variety of disease processes increase NAD + usage, potentially by activated repair processes including PARP enzymes a major user of NAD +8 .The results have high potential relevance for clinical and research applications, follow-up of metabolic interventions and detection of disease-induced NAD + or glutathione deficiency to select patients for treatment
Of note, there may be similar indicative practical limitations for the prostaglandins cytoprotection concept [42,43,44,45,46,47,48,49,50], although the cytoprotection concept is still considered to be one of the major theoretical breakthroughs of how epithelium and endothelium function maintenance can be maintained [7]
A review of obesity pharmacotherapy published on NCBI describes a 12-week AOD 9604 trial in which the treated group lost more body fat than placebo without altering glucose control
User Reviews and Testimonials: Users often report visible skin lightening and a reduction in pigmentation issues